rss
Postgrad Med J 2007;83:87-94 doi:10.1136/pgmj.2006.046078
  • Review

Cryoglobulinaemic vasculitis: classification and clinical and therapeutic aspects

  1. Gerald S Braun1,
  2. Sophia Horster3,
  3. Katrin S Wagner4,
  4. Stephan Ihrler5,
  5. Holger Schmid2
  1. 1Division of Nephrology and Immunology, RWTH University, Aachen, Germany
  2. 2Medical Policlinic, Ludwig-Maximilians-University, Munich, Germany
  3. 3Department of Dermatology, Ludwig-Maximilians-University, Munich, Germany
  4. 4Renal Unit, Department of Medicine II, Klinikum Rechts der Isar, Technical University, Munich, Germany
  5. 5Department of Pathology, Ludwig-Maximilians-University, Munich, Germany
  1. Correspondence to:
 Dr Holger Schmid
 Medizinische Poliklinik, Ludwig-Maximilians-Universität München, Pettenkoferstr 8a, 80336 Munich, Germany; holger.schmid{at}lrz.uni-muenchen.de
  • Received 1 February 2006
  • Accepted 11 August 2006

Abstract

Cryoglobulinaemia may cause cutaneous vasculitis and glomerulonephritis, potentially leading to end stage renal failure. An important proportion of cryoglobulinaemias are secondary to hepatitis C virus infection. Emerging antiviral treatment options offer a chance for causal therapy of these cases of cryoglobulinaemia. This review summarises the classification and clinical and therapeutic aspects of cryoglobulinaemic vasculitis and glomerulonephritis.

Footnotes

  • Funding: None.

  • Competing interests: None.

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.